Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Oct;66(10):100897.
doi: 10.1016/j.jlr.2025.100897. Epub 2025 Sep 8.

Heart DHA turnover is faster in female compared to male ALA- and EPA-fed mice

Affiliations
Comparative Study

Heart DHA turnover is faster in female compared to male ALA- and EPA-fed mice

Ruxandra D Rotarescu et al. J Lipid Res. 2025 Oct.

Abstract

Young females have higher circulating docosahexaenoic acid (DHA) levels than males, though the metabolic basis remains incompletely understood. Building on previous findings that demonstrate higher hepatic synthesis of the DHA precursor, docosapentaenoic acid (DPAn-3), in males, this study extends the investigation to n-3 PUFA turnover in extrahepatic tissues of male and female C57BL/6N mice using compound-specific isotope analysis (CSIA). Animals were fed a 12-week diet enriched in either α-linolenic acid (ALA), eicosapentaenoic acid (EPA), or DHA, starting with a 4-week phase containing low carbon-13 (δ13C)-n-3 PUFA, followed by an 8-week phase with high δ13C-n-3 PUFA (n = 4 per diet, time point, sex). Heart, perirenal adipose tissue (PRAT), brain, and red blood cells (RBCs) were collected at baseline and at seven time points (1-56 days) post-diet switch, with δ13C-n-3 PUFA values modeled by one-phase exponential decay. Compared to males, females exhibited slower turnover of ALA (48%-61% slower) and DPAn-3 (26%-73% slower) from dietary ALA or EPA in the heart, PRAT, and RBCs, resulting from longer half-lives and/or lower DPAn-3 concentrations. Conversely, females showed 26%-28% faster heart DHA turnover from dietary ALA or EPA, despite similar half-lives between sexes. Notably, sex-specific differences in DHA turnover were present only in the heart, whereas DPAn-3 turnover varied across multiple tissues, suggesting a heart-specific mechanism that enhances DHA metabolism in females under low DHA intake. Further research is needed to investigate the physiological significance of these metabolic differences and their potential health implications.

Keywords: DHA turnover; dietary fat; extrahepatic; fatty acid metabolism; kinetics; nutrition; omega-3 fatty acids; polyunsaturated fatty acid; sex differences.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: G. H. A. is the Director of the NSERC University–Industry Collaborative Research Program in Food Safety, Nutrition and Regulatory Affairs at the Department of Nutritional Sciences, Faculty of Medicine, University of Toronto. A. H. M. is on the Board of Directors of the International Society for the Study of Fatty Acids and Lipids, is a Science Advisor for Benexia and Natures Crops International and was a co-applicant on a joint government/industry funded research grant with Natures Crops International.

Figures

Fig. 1
Fig. 1
Mean heart concentrations (μmol/g, bar graph) and relative percent (fatty acid in % total fatty acids, scatterplot) of (A) ALA, (B) EPA, (C) DPAn-3, and (D) DHA of ALA-, EPA-, and DHA-fed mice. ∗ and ∗∗ represent statistically significant differences relative to females within each diet group as determined by an independent t test at P-values < 0.05 and < 0.001, respectively. Values are means ± SEM (n = 28). ALA, α-linolenic acid; DHA, docosahexaenoic acid; DPAn-3, docosapentaenoic acid; EPA, eicosapentaenoic acid.
Fig. 2
Fig. 2
Mean perirenal adipose tissue (PRAT) concentrations (nmol/ml, bar graph) and relative percent (fatty acid in % total fatty acids, scatterplot) of (A) ALA, (B) EPA, (C) DPAn-3, and (D) DHA of ALA-, EPA-, and DHA-fed mice. ∗ and ∗∗ represent statistically significant differences relative to females within each diet group as determined by an independent t test at P-values < 0.05 and < 0.001, respectively. Values are means ± SEM (n = 28). ALA, α-linolenic acid; DHA, docosahexaenoic acid; DPAn-3, docosapentaenoic acid; EPA, eicosapentaenoic acid.
Fig. 3
Fig. 3
Mean brain concentrations (μmol/g, bar graph) and relative percent (fatty acid in % total fatty acids, scatterplot) of (A) ALA, (B) EPA, (C) DPAn-3, and (D) DHA of ALA-, EPA-, and DHA-fed mice. ∗ and ∗∗ represent statistically significant differences relative to females within each diet group as determined by an independent t test at P-values < 0.05 and < 0.001, respectively. Values are means ± SEM (n = 28). ALA, α-linolenic acid; DHA, docosahexaenoic acid; DPAn-3, n-3 docosapentaenoic acid; EPA, eicosapentaenoic acid.
Fig. 4
Fig. 4
Mean red blood cell (RBC) concentrations (nmol/g, bar graph) and relative percent (fatty acid in % total fatty acids, scatterplot) of (A) ALA, (B) EPA, (C) DPAn-3, and (D) DHA of ALA-, EPA-, and DHA-fed mice. ∗ and ∗∗ represent statistically significant differences relative to females within each diet group as determined by an independent t test at P-values < 0.05 and < 0.001, respectively. Values are means ± SEM (n = 28). ALA, α-linolenic acid; DHA, docosahexaenoic acid; DPAn-3, n-3 docosapentaenoic acid; EPA, eicosapentaenoic acid.
Fig. 5
Fig. 5
Summary of significant sex differences in the rate of turnover of n-3 PUFA from dietary ALA and EPA in the heart, perirenal adipose tissue, and red blood cells. Created with BioRender.com. ALA, α-linolenic acid; DHA, docosahexaenoic acid; DPAn-3, n-3 docosapentaenoic acid; EPA, eicosapentaenoic acid; F, females; M, males.

References

    1. Uauy R., Hoffman D.R. Essential fatty acid requirements for normal eye and brain development. Semin. Perinatol. 1991;15:449–455. - PubMed
    1. Bazinet R.P., Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 2014;15:771–785. - PubMed
    1. Regitz-Zagrosek V., Gebhard C. Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat. Rev. Cardiol. 2023;20:236–247. - PMC - PubMed
    1. Abumweis S., Jew S., Tayyem R., Agraib L. Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials. J. Hum. Nutr. Diet. 2018;31:67–84. - PubMed
    1. Serhan C.N. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92–101. - PMC - PubMed

Publication types

LinkOut - more resources